<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Malla P</submitter><funding>Ministry of Science and Technology, Taiwan</funding><funding>Chang Gung University</funding><funding>Chang Gung Memorial Hospital, Linkou</funding><pagination>168</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8973645</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>189(4)</volume><pubmed_abstract>The rapid spread of the novel human coronavirus 2019 (COVID-19) and its morbidity have created an urgent need for rapid and sensitive diagnostics. The real-time polymerase chain reaction is the gold standard for detecting the coronavirus in various types of biological specimens. However, this technique is time consuming, labor intensive, and expensive. Screen-printed electrodes (SPEs) can be used as point-of-care devices because of their low cost, sensitivity, selectivity, and ability to be miniaturized. The ability to detect the spike protein of COVID-19 in serum, urine, and saliva was developed using SPE aided by magnetic beads (MBs) and a portable potentiostat. The antibody-peroxidase-loaded MBs were the captured and catalytic units for the electrochemical assays. The MBs enable simple washing and homogenous deposition on the working electrode using a magnet. The assembly of the immunological MBs and the electrochemical system increases the measuring sensitivity and speed. The physical and electrochemical properties of the layer-by-layer modified MBs were systematically characterized. The performance of these immunosensors was evaluated using spike protein in the range 3.12-200 ng mL&lt;sup>-1&lt;/sup>. We achieved a limit of detection of 0.20, 0.31, and 0.54 ng mL&lt;sup>-1&lt;/sup> in human saliva, urine, and serum, respectively. A facile electrochemical method to detect COVID-19 spike protein was developed for quick point-of-care testing.</pubmed_abstract><journal>Mikrochimica acta</journal><pubmed_title>Voltammetric biosensor for coronavirus spike protein using magnetic bead and screen-printed electrode for point-of-care diagnostics.</pubmed_title><pmcid>PMC8973645</pmcid><funding_grant_id>BMRP 758</funding_grant_id><funding_grant_id>110-2221-E-182-024</funding_grant_id><funding_grant_id>2H0073</funding_grant_id><pubmed_authors>Liu CH</pubmed_authors><pubmed_authors>Wu WC</pubmed_authors><pubmed_authors>Sreearunothai P</pubmed_authors><pubmed_authors>Malla P</pubmed_authors><pubmed_authors>Liao HP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Voltammetric biosensor for coronavirus spike protein using magnetic bead and screen-printed electrode for point-of-care diagnostics.</name><description>The rapid spread of the novel human coronavirus 2019 (COVID-19) and its morbidity have created an urgent need for rapid and sensitive diagnostics. The real-time polymerase chain reaction is the gold standard for detecting the coronavirus in various types of biological specimens. However, this technique is time consuming, labor intensive, and expensive. Screen-printed electrodes (SPEs) can be used as point-of-care devices because of their low cost, sensitivity, selectivity, and ability to be miniaturized. The ability to detect the spike protein of COVID-19 in serum, urine, and saliva was developed using SPE aided by magnetic beads (MBs) and a portable potentiostat. The antibody-peroxidase-loaded MBs were the captured and catalytic units for the electrochemical assays. The MBs enable simple washing and homogenous deposition on the working electrode using a magnet. The assembly of the immunological MBs and the electrochemical system increases the measuring sensitivity and speed. The physical and electrochemical properties of the layer-by-layer modified MBs were systematically characterized. The performance of these immunosensors was evaluated using spike protein in the range 3.12-200 ng mL&lt;sup>-1&lt;/sup>. We achieved a limit of detection of 0.20, 0.31, and 0.54 ng mL&lt;sup>-1&lt;/sup> in human saliva, urine, and serum, respectively. A facile electrochemical method to detect COVID-19 spike protein was developed for quick point-of-care testing.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-04T23:34:39.697Z</modification><creation>2025-04-04T23:34:39.697Z</creation></dates><accession>S-EPMC8973645</accession><cross_references><pubmed>35362759</pubmed><doi>10.1007/s00604-022-05288-4</doi></cross_references></HashMap>